SEC Form 4 · accession 0001615774-16-007184
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director
Period of report
Sep 13, 2016
Accepted (ET)
Sep 14, 2016 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Sep 13, 2016 | P | 100,000 | $0.7918 | A | 530,724 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.791817611. The range of purchase prices on the transaction date was $0.7801 to $0.80 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.